Stay updated on Regeneron Press Releases

Sign up to get notified when there's something new on the Regeneron Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Regeneron Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added two high-impact updates: Libtayo plus chemotherapy shows five-year survival gains in advanced NSCLC, and Regeneron reports two positive Phase 3 allergy trials. Removed older items: donation-matching CSR program and Dupixent BP approval news, shifting the page toward current progress and future pipeline.
    Difference
    100%
    Check dated 2025-09-14T00:20:34.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now includes an updated presentation time for an upcoming investor conference by Regeneron, while a significant announcement regarding Dupixent's superiority in a clinical trial has been removed.
    Difference
    17%
    Check dated 2025-09-06T21:11:09.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The webpage has added a significant announcement regarding Regeneron's positive trial results for a treatment related to Generalized Myasthenia Gravis, while removing a previous announcement about Dupixent's data presented at a conference.
    Difference
    15%
    Check dated 2025-08-30T15:43:32.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now includes an FDA review period extension for EYLEA HD® (aflibercept) Injection, while a previous announcement regarding Regeneron's expansion of its obesity portfolio has been removed.
    Difference
    16%
    Check dated 2025-08-23T14:19:49.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page has added information about Regeneron's upcoming investor conference presentations while removing details about interim results from a clinical trial related to semaglutide.
    Difference
    14%
    Check dated 2025-08-09T08:04:10.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page has added a report on Regeneron's second quarter financial results for 2025 while removing a previous announcement regarding Libtayo's Phase 3 data.
    Difference
    14%
    Check dated 2025-08-02T04:16:01.000Z thumbnail image

Stay in the know with updates to Regeneron Press Releases

Enter your email address, and we'll notify you when there's something new on the Regeneron Press Releases page.